Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gisele Vanessa Baracho"'
Publikováno v:
The Journal of Immunology. 206:27.14-27.14
Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells have become attractive therapeutic targets for cancer immunotherapy because of their efficient mechanisms for killing cancerous cells. Both effector CTLs and mature NK cells are endowed wit
Autor:
Xiaoshan Shi, Gisele Vanessa Baracho, Wai Lin, John Sedy, Chip Lomas, Stephanie Widmann, Aaron J Tyznik
Publikováno v:
The Journal of Immunology. 204:243.17-243.17
The pathogenesis and progression of B-cell lymphomas is a dynamic process involving reciprocal interactions between malignant cells and surrounding components in the tumor microenvironment. Neoplastic B cells migrate to lymphoid sites and prompt the
Autor:
Gisele Vanessa Baracho, Hye-Wong Song, Ian Taylor, Stefanie Mortimer, Stephanie Widmann, Aaron J Tyznik
Publikováno v:
The Journal of Immunology. 204:86.27-86.27
In chronic conditions, notably cancers, CD8+ cytotoxic T cells gradually lose their effector functions due to constant exposure to antigens and consequent upregulation of inhibitory receptors like PD-1. In this regard, PD-1 blockade therapy was shown
Autor:
Edimara, Da Silva Reis, Gisele Vanessa, Baracho, Adriana, Sousa Lima, Chuck S, Farah, Lourdes, Isaac
Publikováno v:
Journal of clinical immunology. 22(6)
C3 deficiency in humans is a rare disorder characterized by severe recurrent infections. We identified the mutations responsible for a complete homozygous C3 deficiency. Sequencing of the proband C3 cDNA (5067 bp) revealed the following alterations: